Synergy Between NK Cells and Monocytes in Potentiating Cardiovascular Disease Risk in Severe COVID-19Manuja Gunasena, Namal P. M. Liyanage, Krishanthi Weragalaarachchi et al.|Arteriosclerosis Thrombosis and Vascular Biology|2024Cited by 6
Unique immune signatures predict potential cardiometabolic risk in severe COVID-19 patients and COVID-19 recovered individualsNamal P. M. Liyanage, Nicholas Funderburg, Manuja Gunasena et al.|The Journal of Immunology|2021Cited by 1
SARS-CoV-2 mediated monocytes dysregulation may contribute to increase risk of cardiovascular risk in severe COVID-19 patientsManuja Gunasena, Namal P. M. Liyanage, Yasasvi Wijewantha et al.|The Journal of Immunology|2021Cited by 0
Synergistic Role of NK Cells and Monocytes in Promoting Atherogenesis in Severe COVID-19 PatientsManuja Gunasena, Namal P. M. Liyanage, Mario Alles et al.|medRxiv|2023Cited by 0